InvestorsHub Logo
Followers 1
Posts 27
Boards Moderated 0
Alias Born 03/02/2011

Re: postmeridiem post# 1014

Thursday, 03/16/2017 10:23:09 PM

Thursday, March 16, 2017 10:23:09 PM

Post# of 1435
They did not give any details on why there would be cost savings for them compared to current treatments; they only said that they could charge half to disrupt the current market and still make a nice profit. No matter how much price competition occurs, TGTX said they should have a big advantage with a one-hour infusion time for TG-1101 versus four hours for other treatments.


Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent TGTX News